Barclays
AVAH icon

Barclays’s Aveanna Healthcare AVAH Stock Holding History

Barclays’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
124,668
-2,107
-2% -$14.9K ﹤0.01% 2752
2026
Q1 		$816K Sell
126,775
-75,581
-37% -$584K ﹤0.01% 2874
2025
Q4 		$1.65M Buy
202,356
+22,997
+13% +$208K ﹤0.01% 3069
2025
Q3 		$1.59M Buy
179,359
+1,366
+0.8% +$8.64K ﹤0.01% 3044
2025
Q2 		$931K Buy
177,993
+62,450
+54% +$317K ﹤0.01% 3390
2025
Q1 		$626K Sell
115,543
-26,152
-18% -$123K ﹤0.01% 3386
2024
Q4 		$648K Buy
141,695
+19,006
+15% +$97.3K ﹤0.01% 3663
2024
Q3 		$638K Buy
122,689
+54,557
+80% +$247K ﹤0.01% 3626
2024
Q2 		$188K Sell
68,132
-17,507
-20% -$43.6K ﹤0.01% 3613
2024
Q1 		$213K Sell
85,639
-33,985
-28% -$82K ﹤0.01% 4085
2023
Q4 		$321K Buy
119,624
+61,011
+104% +$116K ﹤0.01% 4165
2023
Q3 		$69.7K Sell
58,613
-1,423
-2% -$2.2K ﹤0.01% 3723
2023
Q2 		$101K Sell
60,036
-12,910
-18% -$16.2K ﹤0.01% 3559
2023
Q1 		$75.9K Buy
72,946
+10,962
+18% +$13K ﹤0.01% 4313
2022
Q4 		$48.3K Sell
61,984
-1,030
-2% -$1.08K ﹤0.01% 4564
2022
Q3 		$95K Sell
63,014
-36,224
-37% -$74.4K ﹤0.01% 3559
2022
Q2 		$224K Sell
99,238
-4,385
-4% -$12.7K ﹤0.01% 3363
2022
Q1 		$354K Buy
+103,623
New +$563K ﹤0.01% 3104

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Barclays's AVAH Position: Q2 2026 in Review

Barclays reduced its Aveanna Healthcare (AVAH) stake by 1.7% in Q2 2026, selling an estimated $14.9K and leaving 124,668 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

Barclays first reported a position in AVAH in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.65M in Q4 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Barclays held 124,668 shares of Aveanna Healthcare worth $1.07M as of Q2 2026.
  • Barclays sold 2,107 Aveanna Healthcare shares in Q2 2026, an estimated $14.9K.
  • Aveanna Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2752 holding.
  • Barclays first reported a position in Aveanna Healthcare in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Aveanna Healthcare position peaked at $1.65M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.